Redeker, Imke http://orcid.org/0000-0003-3377-2683
Callhoff, Johanna
Hoffmann, Falk
Marschall, Ursula
Haibel, Hildrun
Sieper, Joachim
Zink, Angela
Poddubnyy, Denis
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EC1405)
Article History
Received: 14 April 2020
Accepted: 24 August 2020
First Online: 10 September 2020
Ethics approval and consent to participate
: The study was approved by the ethics committee of the Charité - Universitätsmedizin Berlin, Berlin, Germany. Patients’ written informed consent on the linkage of survey data to health insurance data was obtained in all cases.
: Not applicable.
: I. Redeker, J. Callhoff, F. Hoffmann, and A. Zink declare no conflicts of interest. U. Marschall is an employee of BARMER. H. Haibel reports consulting fees or members of the speakers’ bureau from AbbVie, Janssen, MSD, Novartis, Pfizer, and Roche. J. Sieper reports consulting fees or members of the speakers’ bureau from AbbVie, Janssen, Lilly, MSD, Novartis, and Pfizer and grants from AbbVie, MSD, and Pfizer. D. Poddubnyy reports consulting fees or members of the speakers’ bureau from AbbVie, BMS, Celgene, Lilly, MSD, Novartis, Pfizer, Roche, and UCB and grants from AbbVie, MSD, Novartis, and Pfizer.